Screener
Moderna MRNA Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Moderna’s 8-K, filed July 31, 2026. Open the filing →
- Filed
- Jul 31, 2026, 7:03 AM EDT
- Accession
- 0001682852-26-000147
FAQ
- What is Moderna's other income, net (note 6)?
- Moderna (MRNA) reported other income, net (note 6) of -$19M in Q2 2026.
- How has Moderna's other income, net (note 6) changed year-over-year?
- Moderna's other income, net (note 6) decreased by 337.5% year-over-year, from $8M to -$19M.
- What is the long-term trend for Moderna's other income, net (note 6)?
- Over 4 years (2021 to 2025), Moderna's other income, net (note 6) has grown at a -27.5% compound annual growth rate (CAGR), from -$29M to -$8M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.
Ask your AI about Moderna's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude